Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.

Also called NCT06358313

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 600 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06358313
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06358313. Randomized; double masking; primary purpose treatment. Start 2024-04-10 (actual); primary completion 2026-05-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke
Intervention (Drug)
Atorvastatin 40mg
Intervention (Drug)
Rosuvastatin 20mg
Lead sponsor
Kafrelsheikh University (class: other)

Record details

Record id
cardio:ct-nct06358313
Content hash
2c70d39b1122bf7094d93708a71117d5f8401eea1c02c193ded8704f7178464b